A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Researchers said weight-loss drugs could affect health in eye-opening ways, but other experts say more work needs to be done ...

EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...

Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...